List of works - Kara Anasti

A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice

scientific article published on 26 January 2022

Antigenicity and Immunogenicity of HIV-1 Envelope Trimers complexed to a Small-Molecule Viral Entry Inhibitor

scientific article published on 19 August 2020

Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion

scientific article published on 21 November 2012

Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines

scientific article published on 22 August 2013

Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation

scientific article published on 14 September 2011

HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies

scientific article

Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice

scientific article published on 23 December 2016

Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies

scientific article

Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum

scientific article

Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.

scientific article published on March 2017

Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens

scientific article published on 24 November 2010

Potent and broad HIV-neutralizing antibodies in memory B cells and plasma

scientific article published on January 2017

Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors.

scientific article published on 21 October 2013

Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies

scientific article published in Nature Communications

Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site

scientific article

Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates

scientific article

List of works by Kara Anasti

A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice

Antigenicity and Immunogenicity of HIV-1 Envelope Trimers complexed to a Small-Molecule Viral Entry Inhibitor

Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion

Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines

Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation

HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies

Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice

Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies

Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum

Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.

Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens

Potent and broad HIV-neutralizing antibodies in memory B cells and plasma

Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors.

Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies

Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site

Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates